Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine on Symptomatic SARS-CoV-2 Infection and COVID-19-related Hospitalizations, Mortality, and Long-term Consequences in Brazil: a Real-world Evidence Study

NCT05052307 is registered in ClinicalTrials.gov with Hospital Moinhos de Vento as lead sponsor.

NCT NCT05052307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05052307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine on Symptomatic SARS-CoV-2 Infection and COVID-19-related Hospitalizations, Mortality, and Long-term Consequences in Brazil: a Real-world Evidence Study
Lead sponsor
Hospital Moinhos de Vento
Phase
Observational
Overall status
Completed
Start date
November 3, 2021
Completion date
July 20, 2023
Enrollment
4,574 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid19